Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Robert Sarkany

Showing results (11-20 of 27) with videos related to

Pageof 3
Sort By:
Health Psychology : Official Journal of the Division of Health Psychology, American Psychological Association|September 18, 2018
Understanding and predicting a complex behavior using n-of-1 methods: Photoprotection in xeroderma pigmentosumKirby Sainsbury, Rute Vieira, Jessica Walburn, et al.
Photodermatology, Photoimmunology & Photomedicine|October 10, 2019
Facial photoprotection in xeroderma pigmentosum (XP) patients: Validation of a new self-reported questionnaire of adherenceMartha Canfield, Sam Norton, Jessica Walburn, et al.
Clinical Transplantation|October 23, 2012
Determinants of vitamin D status in long-term renal transplant patientsHugo Penny, Sharon Frame, Francis Dickinson, et al.
Clinical and Experimental Dermatology|January 7, 2026
Narrowband ultraviolet-B (NB-UVB) Minimal Erythema Dose (MED) Reference RangeEwan Eadie, Brian Todd, Sanchez Luzvminda, et al.
Frontiers in Oncology|November 13, 2023
Retrospective study of efficacy and adverse events of immune checkpoint inhibitors in 22 xeroderma pigmentosum patients with metastatic or unresectable cancersElvelyn R Fernandez, Deborah Tamura, Sikandar G Khan, et al.
Journal of Medical Genetics|April 8, 2022
Identifying the psychosocial predictors of ultraviolet exposure to the face in patients with xeroderma pigmentosum: a study of the behavioural factors affecting clinical outcomes in this genetic diseaseRobert Sarkany, Sam Norton, Martha Canfield, et al.
Acta Dermato-Venereologica|June 27, 2018
Sub-optimal Application of a High SPF Sunscreen Prevents Epidermal DNA Damage in VivoAntony R Young, Jessica Greenaway, Graham I Harrison, et al.
British Journal of Health Psychology|June 12, 2019
Psychological correlates of adherence to photoprotection in a rare disease: International survey of people with Xeroderma PigmentosumJessica Walburn, Martha Canfield, Sam Norton, et al.
Cold Spring Harbor Molecular Case Studies|October 25, 2019
Dramatic response of metastatic cutaneous angiosarcoma to an immune checkpoint inhibitor in a patient with xeroderma pigmentosum: whole-genome sequencing aids treatment decision in end-stage diseaseSophie Momen, Hiva Fassihi, Helen R Davies, et al.
BMJ Open|August 23, 2017
An investigation of the predictors of photoprotection and UVR dose to the face in patients with XP: a protocol using observational mixed methodsJessica Walburn, Robert Sarkany, Sam Norton, et al.
Pageof 3

Showing results (11-20 of 27) with videos related to

Sort By:
Pageof 3
Health Psychology : Official Journal of the Division of Health Psychology, American Psychological Association|September 18, 2018
Understanding and predicting a complex behavior using n-of-1 methods: Photoprotection in xeroderma pigmentosumKirby Sainsbury, Rute Vieira, Jessica Walburn, et al.
Photodermatology, Photoimmunology & Photomedicine|October 10, 2019
Facial photoprotection in xeroderma pigmentosum (XP) patients: Validation of a new self-reported questionnaire of adherenceMartha Canfield, Sam Norton, Jessica Walburn, et al.
Clinical Transplantation|October 23, 2012
Determinants of vitamin D status in long-term renal transplant patientsHugo Penny, Sharon Frame, Francis Dickinson, et al.
Clinical and Experimental Dermatology|January 7, 2026
Narrowband ultraviolet-B (NB-UVB) Minimal Erythema Dose (MED) Reference RangeEwan Eadie, Brian Todd, Sanchez Luzvminda, et al.
Frontiers in Oncology|November 13, 2023
Retrospective study of efficacy and adverse events of immune checkpoint inhibitors in 22 xeroderma pigmentosum patients with metastatic or unresectable cancersElvelyn R Fernandez, Deborah Tamura, Sikandar G Khan, et al.
Journal of Medical Genetics|April 8, 2022
Identifying the psychosocial predictors of ultraviolet exposure to the face in patients with xeroderma pigmentosum: a study of the behavioural factors affecting clinical outcomes in this genetic diseaseRobert Sarkany, Sam Norton, Martha Canfield, et al.
Acta Dermato-Venereologica|June 27, 2018
Sub-optimal Application of a High SPF Sunscreen Prevents Epidermal DNA Damage in VivoAntony R Young, Jessica Greenaway, Graham I Harrison, et al.
British Journal of Health Psychology|June 12, 2019
Psychological correlates of adherence to photoprotection in a rare disease: International survey of people with Xeroderma PigmentosumJessica Walburn, Martha Canfield, Sam Norton, et al.
Cold Spring Harbor Molecular Case Studies|October 25, 2019
Dramatic response of metastatic cutaneous angiosarcoma to an immune checkpoint inhibitor in a patient with xeroderma pigmentosum: whole-genome sequencing aids treatment decision in end-stage diseaseSophie Momen, Hiva Fassihi, Helen R Davies, et al.
BMJ Open|August 23, 2017
An investigation of the predictors of photoprotection and UVR dose to the face in patients with XP: a protocol using observational mixed methodsJessica Walburn, Robert Sarkany, Sam Norton, et al.
Pageof 3